BioCorRx (BICX) Cash from Financing Activities (2010 - 2026)
BioCorRx (BICX) recorded Cash from Financing Activities of $505,522 in Q1 2026, down 19.2% from $625,732 a year earlier and down 27.7% from the prior quarter.
Powered by 
Analysis
BioCorRx (BICX) Cash from Financing Activities (2010 - 2026) Analysis & Trends
On a TTM basis, BioCorRx's Cash from Financing Activities came in at $2.23 million as of Mar 31, 2026, up 62.8% year-over-year; for FY2025, it was $2.35 million, up 110.0% from FY2024.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of 85.4% (FY2020 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $1.12 million in FY2024 (-39.5%), $1.85 million in FY2023 (-8.6%), $2.02 million in FY2022 (-34.3%) and $3.08 million in FY2021.
- Quarterly Cash from Financing Activities has ranged from $59,158 in Q2 2024 to $1 million in Q1 2022 over the past five years.
- On a year-over-year basis, Cash from Financing Activities rose in five of the last eight quarters, with growth averaging 56.2%.
- Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 842.1% in Q3 2021, against a decline of 89.5% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $699,394 (Q4 2025), $810,263 (Q3 2025) and $214,229 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | BioCorRx | 4.32 Mn | 3.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 505,522.00 |
| Dec 31, 2025 | 699,394.00 |
| Sep 30, 2025 | 810,263.00 |
| Jun 30, 2025 | 214,229.00 |
| Mar 31, 2025 | 625,732.00 |
| Dec 31, 2024 | 335,113.00 |
| Sep 30, 2024 | 349,268.00 |
| Jun 30, 2024 | 59,158.00 |
| Mar 31, 2024 | 375,526.00 |
| Dec 31, 2023 | 442,649.00 |
| Sep 30, 2023 | 309,653.00 |
| Jun 30, 2023 | 565,160.00 |
| Mar 31, 2023 | 532,427.00 |
| Dec 31, 2022 | 454,662.00 |
| Sep 30, 2022 | 319,888.00 |
| Jun 30, 2022 | 250,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Sep 30, 2021 | 700,000.00 |
| Jun 30, 2021 | 131,440.00 |
| Mar 31, 2021 | 2.25 Mn |
API Access
BioCorRx Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();